Ua hoʻokumu ʻia ʻo Shenzhen JYMed Technology Co., Ltd. (ma hope aku i kapa ʻia ʻo JYMed) i ka makahiki 2009, ʻoihana loea i ka noiʻi, hoʻomohala, hana, a kūʻai aku i nā peptides a me nā huahana pili i ka peptide. Me hoʻokahi kikowaena noiʻi a me ʻekolu kumu hana nui, ʻo JYMed kekahi o nā mea hana nui loa o nā peptide chemically synthesized API ma Kina. Ua hoʻokiʻekiʻe ka hui R&D koʻikoʻi o ka hui ma mua o 20 mau makahiki o ka ʻike ma ka ʻoihana peptide a ua lanakila ʻelua i ka nānā ʻana o FDA. Hāʻawi ka ʻōnaehana peptide industrialization a JYMed i nā mea kūʻai aku i nā lawelawe holoʻokoʻa, me ka hoʻomohala ʻana a me ka hana ʻana o nā peptides therapeutic, nā peptides holoholona, ​​​​nā peptides antimicrobial, a me nā peptides cosmetic, a me ke kākau inoa ʻana a me ke kākoʻo hoʻoponopono.

Nā Hana Hana Nui

1. Ka hoʻopaʻa inoa ʻana i ka home a me ka honua o nā API peptide

2. Veterinary a me nā peptides cosmetic

3.Custom peptides a me nā lawelawe CRO, CMO, OEM

4.PDC nā lāʻau (peptide-radionuclide, peptide-liʻiliʻi mole, peptide-protein, peptide-RNA)

Ma kahi o Tirzepatide, ua hoʻouna ʻo JYMed i nā palapala hoʻopaʻa inoa me ka FDA a me CDE no nā huahana API ʻē aʻe, me nā lāʻau lapaʻau GLP-1RA kaulana i kēia manawa e like me Semaglutide a me Liraglutide. Hiki i nā mea kūʻai aku e hoʻohana ana i nā huahana a JYMed ke kuhikuhi pololei i ka helu hoʻopaʻa inoa CDE a i ʻole ka helu faila DMF i ka wā e hoʻouna ana i nā noi hoʻopaʻa inoa i ka FDA a i ʻole CDE. E hōʻemi nui kēia i ka manawa e pono ai no ka hoʻomākaukau ʻana i nā palapala noi, a me ka manawa loiloi a me ke kumukūʻai o ka loiloi huahana.